RxDoctor Payments DataLook up a doctor →

Filip Janku

Internal Medicine · Houston, TXNPI 1740584507

Payments from drug & device makers

$10,213,954in general payments, 2019–2025

Across 1,652 payments — averaging $6182.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Deciphera Pharmaceuticals Inc.$3.6M
  • Novartis$1.9M
  • E.r. Squibb & Sons, L.L.C.$1.3M
  • Merck$1.1M
  • Otsuka Pharmaceutical Co., Ltd.$693K
  • Synthorx Inc.$606K
  • plus $992K from 10 others
$2,067in research payments, 2019–2025

Across 5 payments — averaging $413.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2K
  • E.r. Squibb & Sons, L.L.C.$130

What the payments were for

  • Consulting fees$7,81376%
  • Speaking & faculty fees$1,62516%
  • Travel & lodging$8538%
  • Food & beverage$420%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,213,954 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Other internal medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →